Country: United States
Language: English
Source: NLM (National Library of Medicine)
VECURONIUM BROMIDE (UNII: 7E4PHP5N1D) (VECURONIUM - UNII:5438723848)
Akorn - Strides LLC
VECURONIUM BROMIDE
VECURONIUM 1 mg in 1 mL
INTRAVENOUS
PRESCRIPTION DRUG
Vecuronium bromide is indicated as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Vecuronium bromide is contraindicated in patients known to have a hypersensitivity to it.
Vecuronium Bromide for Injection is supplied as follows: 10 mg vecuronium bromide, NDC 23360-160-08 Box of 10. 20 mg vecuronium bromide, NDC 23360-160-10 Box of 10. Store dry powder at 20o to 25o C (68o to 77o F) [see USP Controlled Room Temperature]. Protect from light. Retain in carton until time of use. Akorn-Strides, LLC Lake Forest, IL 60045 Made in India STVE00N Revision: August 2008
Abbreviated New Drug Application
VECURONIUM BROMIDE - VECURONIUM BROMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION AKORN - STRIDES LLC ---------- VECURONIUM BROMIDE FOR INJECTION VECURONIUM BROMIDE FOR INJECTION RX ONLY THIS DRUG SHOULD BE ADMINISTERED BY ADEQUATELY TRAINED INDIVIDUALS FAMILIAR WITH ITS ACTIONS, CHARACTERISTICS, AND HAZARDS. DESCRIPTION Vecuronium Bromide for Injection is a nondepolarizing neuromuscular blocking agent of intermediate duration, chemically designated as 1-(3α,17β-Dihydroxy-2β-piperidino-5α- androstan-16β,5α-yl)-1- methylpiperidinium bromide, diacetate. The structural formula is: Its chemical formula is C H BrN O with molecular weight 637.75. Vecuronium Bromide for Injection is supplied as a sterile nonpyrogenic freeze-dried buffered cake of very fine microscopic crystalline particles for intravenous injection only. Each vial contains 10 mg or 20 mg of vecuronium bromide. In addition, each 10 mg vial contains 20.75 mg citric acid anhydrous, 16.25 mg sodium phosphate dibasic anhydrous, 97 mg mannitol (to adjust tonicity), sodium hydroxide and/or phosphoric acid to buffer and adjust to a pH range of 3.5 to 4.5. Each 20 mg vial contains 41.5 mg citric acid anhydrous, 32.5 mg sodium phosphate dibasic anhydrous, 194 mg mannitol (to adjust tonicity), sodium hydroxide and/or phosphoric acid to buffer and adjust to a pH range of 3.5 to 4.5. CLINICAL PHARMACOLOGY Vecuronium is a nondepolarizing neuromuscular blocking agent possessing all of the characteristic pharmacological actions of this class of drugs (curariform). It acts by competing for cholinergic receptors at the motor end-plate. The antagonism to acetylcholine is inhibited and neuromuscular block is reversed by acetylcholinesterase inhibitors such as neostigmine, edrophonium, and pyridostigmine. Vecuronium is about 1/3 more potent than pancuronium; the duration of neuromuscular blockade produced by vecuronium is shorter than that of pancuronium at initially equipotent doses. The time to onset of paralysis decreases and the duration of maximum effect incre Read the complete document